AVTX-801 D-galactose Supplementation in SLC35A2-CDG

Clinical trial NCT05402384 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05402384
Sponsor: Eva Morava-Kozicz
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation

Start date: 2027-01-01
Primary completion: 2028-03-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.